Showing results (1791-1800 of 1,800) with videos related to

Sort By:
Pageof 180
You have reached the last page of results.This site can display upto 1,800 results.
Hepatology Communications|August 11, 2026
Simplified definition and imaging-based stratification of at-risk MASH using magnetic resonance elastographyJiahui Li, Hao Wu, Kevin J Glaser, et al.
Hepatology Communications|August 11, 2026
Micronutrient deficiencies in ambulatory adults with cirrhosisMelinda Wang, Kathy Pariani, Fawzy Barry, et al.
Hepatology Communications|August 11, 2026
Liver-directed gene therapy results in amelioration of progressive familial intrahepatic cholestasis type 2 in miceAngie Molina, Laia Trigueros-Motos, Manuela Molina, et al.
Hepatology Communications|August 18, 2026
Hepatic stellate cell subpopulations in human MASLD-related hepatocellular carcinoma upregulate YAP via geranylgeranyl pyrophosphateCourtney L Labrecque, Arthur Ko, Bo Qiao, et al.
Hepatology Communications|August 20, 2026
Symptom burden is associated with health-related quality of life in symptomatic adults with primary sclerosing cholangitisDonna M Evon, Kaya Merkler, Chelsea Anderson, et al.
Hepatology Communications|August 20, 2026
A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogsWen-Juei Jeng, Chi-Jen Chu, Apinya Leerapun, et al.
Hepatology Communications|September 1, 2026
Measuring quality of life in advanced chronic liver disease with FACT-Hep: Findings from the PAL LIVER trialManisha Verma, Binu V John, Don Rockey, et al.
Hepatology Communications|September 2, 2026
HLA and non-HLA genetic analyses reveal suggestive variants associated with statin-induced liver injuryCallie Jo Zaborenko, Tae-Hwi Schwantes-An, Yi-Ju Li, et al.
Hepatology Communications|May 23, 2025
Skeletal muscle and MASLD: Mechanistic and clinical insightsThomas Marjot, Matthew J Armstrong, Jonathan G Stine
Hepatology Communications|September 16, 2026
Prime editing models the MTARC1 A165T variant in human liver organoids, demonstrating reduced steatosis, inflammation, and fibrosisAmel Ben Saad, Nahid Arghiani, Arden D Weilheimer, et al.
Pageof 180